incyte corp (INCY:NASDAQ GS)
Earnings & Estimates Summary - INCYTE CORP (INCY)
2013 revenues at Incyte Corporation totaled $354.9M USD, while annual losses equaled $0.44 per share.
Quarterly Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Earnings
Incyte Corporation reported 1st quarter 2014 losses of $0.20 per share on 05/3/2014.
Annual Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Annual Earnings
Incyte Corporation reported annual 2013 losses of $0.44 per share on 02/14/2014.
Quarterly Revenues - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Revenues
Incyte Corporation had 1st quarter 2014 revenues of $89.8M USD. This missed the $97.1M USD consensus estimate of the 14 analysts following the company. This was 26.3% above the prior year's 1st quarter results.
Annual Revenues - INCYTE CORP (INCY)
Incyte Corporation's Annual Revenues
Incyte Corporation had revenues for the full year 2013 of $354.9M USD. This was 19.5% above the prior year's results.
|ARIAD Pharmaceuticals Inc||$6.09 USD||+0.14|
|Array BioPharma Inc||$4.07 USD||+0.01|
|Evotec AG||€3.63 EUR||+0.031|
|Exelixis Inc||$3.33 USD||+0.075|
|GlaxoSmithKline SAE||£12.80 EGP||0.00|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|